Davita Highlights Continued Progress In Value-Based Kidney Care As CKCC Results Show Year-Over-Year Improvement

mental-health-policy

DaVita, a comprehensive kidney care provider, is demonstrating significant progress in value-based care models that deliver coordinated treatment for chronic kidney disease. The company’s results from the Comprehensive Kidney Care Contracting (CKCC) program, a federally sponsored innovation model run by the Centers for Medicare and Medicaid Services, show improvements across both quality metrics and financial performance.

Quality and Clinical Outcomes

DaVita achieved a 9% improvement in its Total Quality Score, driven by gains in optimal treatment starts, patient activation, and behavioral health support. Results show that patients with access to CKCC and related value-based programs are more likely to begin kidney replacement therapy with a planned or optimal start, including increased use of home-based treatment options. These patients also experience lower rates of central venous catheter use and fewer missed treatments, reflecting stronger engagement and care coordination.

Financial and Workforce Impact

Since the CKCC program’s inception, DaVita entities have delivered more than $200 million in shared savings. The company accounted for 34% of the program’s High Performers Pool while representing just 28 of program participants. DaVita has been engaged in value-based care arrangements for more than two decades and now manages more than $5 billion in medical costs under management.

Broader Healthcare Implications

According to Dr. Jeff Giulian, DaVita’s chief medical officer, people living with kidney disease often manage multiple chronic conditions, and coordinated care across clinical settings improves outcomes. The improvements in transplant rates and patient understanding of their condition enable more informed, proactive health decisions. Misha Palecek, chief transformation officer, noted that value-based kidney care demonstrates what is possible when providers invest in coordinated care, with better-prepared patients, improved experiences, and encouraging economics. DaVita serves approximately 295,000 patients at 3,242 outpatient dialysis centers worldwide.


This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://menafn.com/1110879699/Davita-Highlights-Continued-Progress-In-Value-Based-Kidney-Care-As-CKCC-Results-Show-Year-Over-Year-Improvement